What BPC-157 is
BPC stands for body protection compound. It's a peptide, a short chain of amino acids, described as occurring naturally in human gastric juice, where it helps maintain the stomach lining. It was first described in 1992 and is sometimes called a gastric pentadecapeptide.
It's promoted online for tendon, ligament, muscle and gut healing. Those claims come mostly from animal studies, not trials in people.
What the research shows
A 2025 systematic review in HSS Journal looked at BPC-157 in orthopedic and sports medicine:
- 36 studies met its criteria: 35 preclinical (animal or lab) and 1 in people.
- In rats and rabbits, BPC-157 improved healing after tendon, ligament, muscle and bone injuries.
- The one human study was a look back at 12 people with knee pain who had BPC-157 injected into the knee. Seven reported feeling better for more than 6 months. There was no comparison group.
- The authors concluded there isn't enough clinical data for evidence-based use and that safety in humans remains unknown.
Animal results often don't carry over to people. Until controlled human trials are done, nobody can say whether BPC-157 helps people heal or what harms it may cause.
Safety and FDA status
BPC-157 is not FDA-approved for any use, and FDA has raised safety concerns about it. See peptide therapy safety for where FDA stands across peptides.
- Products labeled "research use only" are not reviewed or made for people and may not contain what the label says.
- The review's authors flag risks from unregulated manufacturing and contamination.
- The World Anti-Doping Agency has banned BPC-157 since 2022, which matters for competitive athletes.
If you've used an injectable peptide and get redness, swelling, warmth or pus at the site, fever, hives, swelling of the face or throat, or trouble breathing, get medical care right away.
How Gabriel approaches BPC-157
Clinicians reviewing requests through Gabriel don't prescribe research peptides such as BPC-157, TB-500 or epitalon, and Gabriel never gives peptide dosing or sourcing. If you're dealing with a slow-healing injury or gut problem, Gabriel can help you find and book a clinician to look at the cause and the options with stronger evidence.
Common questions
What is BPC-157?
A 15-amino-acid peptide first described from human stomach juice. It isn't FDA-approved for any use, and research is mostly in animals.
Does BPC-157 work?
In animals it improved healing of tendons, ligaments, muscle and bone. In people there's only one small, uncontrolled study, so it's unknown whether it works.
Is BPC-157 safe?
Safety in humans is unknown, and FDA has raised safety concerns. See peptide therapy safety.
Is BPC-157 FDA-approved?
No. It isn't approved for any use. See peptide therapy safety for FDA's current position.
Can Gabriel prescribe BPC-157?
No. Clinicians reviewing requests through Gabriel don't prescribe research peptides such as BPC-157, and Gabriel doesn't give peptide dosing or sourcing.
Sources
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (HSS Journal, 2025) HSS Journal (via PubMed Central)
- Certain bulk drug substances for use in compounding that may present significant safety risks U.S. Food and Drug Administration
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee U.S. Food and Drug Administration
This guide is general information, not medical advice. It does not replace a visit with a licensed clinician. Gabriel membership is not health insurance.